Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.763 | 0.160 | 11 | 18026269 | intron variant | G/T | snv | 0.33 |
|
Mental Disorders | 0.040 | 1.000 | 4 | 2011 | 2019 | |||||||
|
0.763 | 0.160 | 11 | 18026269 | intron variant | G/T | snv | 0.33 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2012 | 2012 | |||||||
|
0.763 | 0.160 | 11 | 18026269 | intron variant | G/T | snv | 0.33 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2012 | 2019 | |||||||
|
1.000 | 11 | 18033757 | intron variant | T/G | snv | 0.19 |
|
Pathological Conditions, Signs and Symptoms | 0.020 | 1.000 | 2 | 2015 | 2018 | ||||||||
|
1.000 | 0.160 | 11 | 18040935 | 5 prime UTR variant | T/A | snv | 0.19 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
1.000 | 0.160 | 11 | 18040935 | 5 prime UTR variant | T/A | snv | 0.19 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.763 | 0.160 | 11 | 18026269 | intron variant | G/T | snv | 0.33 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.763 | 0.160 | 11 | 18026269 | intron variant | G/T | snv | 0.33 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.763 | 0.160 | 11 | 18026269 | intron variant | G/T | snv | 0.33 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.763 | 0.160 | 11 | 18026269 | intron variant | G/T | snv | 0.33 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.763 | 0.160 | 11 | 18026269 | intron variant | G/T | snv | 0.33 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.763 | 0.160 | 11 | 18026269 | intron variant | G/T | snv | 0.33 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.763 | 0.160 | 11 | 18026269 | intron variant | G/T | snv | 0.33 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.763 | 0.160 | 11 | 18026269 | intron variant | G/T | snv | 0.33 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.763 | 0.160 | 11 | 18026269 | intron variant | G/T | snv | 0.33 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.763 | 0.160 | 11 | 18026269 | intron variant | G/T | snv | 0.33 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.763 | 0.160 | 11 | 18026269 | intron variant | G/T | snv | 0.33 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.763 | 0.160 | 11 | 18026269 | intron variant | G/T | snv | 0.33 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 11 | 18019049 | 3 prime UTR variant | T/C | snv | 0.47 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 11 | 18033757 | intron variant | T/G | snv | 0.19 |
|
0.010 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
1.000 | 11 | 18033757 | intron variant | T/G | snv | 0.19 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 11 | 18033757 | intron variant | T/G | snv | 0.19 |
|
0.010 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
11 | 18039853 | intron variant | T/C | snv | 0.78 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
11 | 18042430 | upstream gene variant | A/T | snv | 0.65 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
1.000 | 0.040 | 11 | 18038806 | intron variant | C/T | snv | 0.36 |
|
Digestive System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 |